Skip to Main Content

Investor Relations

Ordinary share
TASE: NXFR
As of 15 min delay
Late rate
Market cap. (M)
ILS
Change
Change
Volume
ILS
Day high
Day low
Year high
Year low

Corporate Presentation

Nextferm is a food-tech company that is developing and producing novel active ingredients based on in-house yeast development & fermentation and for human nutrition.

Download corporate presentation

Hebrew PDF

Press Releases

Date Description Download
25 July.2021 NextFerm Technologies Announces First Commercial Purchase Order of ProteVin™ in the US English PDF Hebrew PDF
11 July.2021 NextFerm Technologies Announces a Regulatory marketing approval of Astaferm® in Canada English PDF Hebrew PDF
06 June.2021 NextFerm Technologies Announces a Successful Industrial Pilot Of ProteVin™ English PDF Hebrew PDF
27 May.2021 NextFerm Reports First Quarter 2021 Financial Results Hebrew PDF
22 Mar.2021 NextFerm Reports Fourth Quarter and Full Year 2020 Financial Results Hebrew PDF
22 Feb.2021 NextFerm Technologies announces Launch of its antioxidant Astaferm® Gummies by Carlson Labs, a Leading US Dietary Supplement Company Hebrew PDF
02 Feb.2021 Management of NextFerm Technologies Opens Trading in Celebration of Its IPO on TASE Hebrew PDF
24 Jan.2021 NextFerm Technologies Announces Closing of Initial Public Offering Hebrew PDF

Financial Reports & Filings

Immediate
Reports

View TASE filings

Financials

Date Description Download
27 May.2021 1st Quarter 2021 - Heb Hebrew PDF
21 Mar.2021 2020 Annual FS - Heb Hebrew PDF

Please contact us for further information

IR contact

Investor Relations
Meirav Gomeh-Bauer
meirav@bauerg.com
054-4764979
CFO
Yossi Ohana
yossio@nextferm.com
This website uses cookies to ensure you get the best experience on our website